Partnerships/ Joint Ventures News from StratCenter.com News Archive
StratWire - Complete Business of Joint Ventures Newsfeed
http://www.myhealthcarenews.com/RSS/HCC0046.xml
Latest news articles from Partnerships/ Joint Ventures News from StratCenter.com:
- Local firm forms foundation for women's sexual health
- Lifeline Therapeutics to Recognize Previously Deferred Retail Chain Revenue
- Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- NextGen Healthcare and Primetime Medical Software Partner to Enhance Communications Between Doctors and Patients
- 3 Keane Executives to Present at the 2006 Gartner Healthcare Summit in San Diego
- Yaupon Therapeutics Closes $4 mln Financing
- CareTech Solutions and Yampa Valley Med Cntr Announce New IT Outsourcing Agreement
- Genelabs Technologies Reports Financial Results for Q3 and 1st 9 Months of 2006
- Frost & Sullivan Honors Covance for Superior Market Leadership, Creating Enhanced Customer Value in the North American CRO Market
- Health Care Property Closes $1B Offering
- - Webcast Alert: Isis Pharmaceuticals Announces Its Analyst/Investor Webcast Presentation
- Tm Bioscience to explore strategic alternatives
- CORD:USE Cord Blood Bank and The Winnie Palmer Hospital Partner To Create the Largest Cord Blood Collection Program in the Nation
- Schering-Plough to Webcast Presentation Credit Suisse Health Care Conference
- Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex Injection Patent Litigation
- Crowell & Moring Adds 23 Lawyers in WA and NY
- Nordic Naturals New High-Concentrate EFA Product Targets Joint and Immune Health
- Numerous New Targets, Increased Use of Drugs in Combination, and Premium Pricing are Contributors to the Enormous Sales Potential of Novel Cancer Therapies Entering the Market Over the Next 15 Years
- BioElectronics Corp Announces Lawrence H Rosen Joins Company as CFO
- NicOx Presents Preclinical Results at AHA From Antihypertensive Collaboration With Merck &., Inc.